Abstract
Background
Tension-type headache is the most common headache to be seen in clinical practice. Depression is highly prevalent in chronic tension-type headache (CTTH) patients attending the clinical settings. Cognitive impairment and neuroendocrine dysregulation had been reported in patients with depression and patients with CTTH.
Objective
To assess the cognitive performance and investigate its possible relations to neuroendocrine levels in patients with CTTH.
Subjects and methods
Patients with CTTH, depression, and control subjects were recruited. CTTH was diagnosed according to the International Classification of Headache Disorders. Cognitive performance, depression severity, and pain intensity were assessed by the Montreal Cognitive Assessment Arabic version, Beck’s Depression Inventory, and McGill Pain Questionnaire respectively. Blood samples were collected in the morning within 60 min after waking up from 8:00 to 9:00 a.m. to measure serum levels of basal plasma CRH, ACTH, Cortisol, TSH, FT3, and FT4.
Results
Both patients with CTTH and depression had impaired cognitive performance. Patients with CTTH and patients with depression had altered the hypothalamus-pituitary-adrenal axis, and pituitary-thyroid axis. The hormonal levels significantly correlated with cognitive function in patient groups, especially patients with CTTH.
Conclusion
Patients with CTTH had cognitive dysfunction which could be related to neuroendocrine hormonal dysregulation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Prince Sattam bin Abdulaziz University, Neurology Department, College of Medicine, Alkharj, Kingdom of Saudi Arabia (GRID:grid.449553.a); Minia University, Neurology Department, Faculty of Medicine, Minia, Egypt (GRID:grid.411806.a) (ISNI:0000 0000 8999 4945)
2 Prince Sattam bin Abdulaziz University, Psychiatry Department, College of Medicine, Alkharj, Kingdom of Saudi Arabia (GRID:grid.449553.a); Minia University, Psychiatry Department, Faculty of Medicine, Minia, Egypt (GRID:grid.411806.a) (ISNI:0000 0000 8999 4945)
3 Prince Sattam bin Abdulaziz University, Neurology Department, College of Medicine, Alkharj, Kingdom of Saudi Arabia (GRID:grid.449553.a)
4 Minia University, Department of Internal Medicine, Faculty of Medicine, Minia, Egypt (GRID:grid.411806.a) (ISNI:0000 0000 8999 4945)
5 Minia University, Faculty of Medicine, Minia, Egypt (GRID:grid.411806.a) (ISNI:0000 0000 8999 4945)